For each follow-up BMI measurement, percentage BMI change was calculated as follow-up BMI minus baseline BMI, divided by baseline BMI
However, when used with insulin or sulfonylureas, dose adjustments of these agents may be needed to prevent hypoglycemia, as with all GLP-1 receptor agonists
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
If these findings are borne out in larger studies over extended follow-up periods, it could possibly be the most dramatic change in treating Type 1 diabetes since the discovery of insulin in 1921. Dandonas co-authors are Ajay Chaudhuri, clinical professor, chief of endocrinology at UB and a physician with UBMD Internal Medicine, and Husam A
Seek urgent medical care if you experience persistently elevated blood glucose (above 300 mg/dL), symptoms of severe hyperglycemia (excessive thirst, frequent urination, fatigue), dehydration, or signs of diabetic ketoacidosis (nausea, vomiting, abdominal pain, rapid breathing, fruity breath odor)